chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the injection site has a little pimple; Tingling on my right foot; Numbness on my right foot; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on my right foot), HYPOAESTHESIA (Numbness on my right foot), DERMATITIS ACNEIFORM (the injection site has a little pimple) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0061321A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site). On 17-Mar-2021, the patient experienced PARAESTHESIA (Tingling on my right foot) and HYPOAESTHESIA (Numbness on my right foot). On an unknown date, the patient experienced DERMATITIS ACNEIFORM (the injection site has a little pimple). The patient was treated with CORTISONE on 16-Mar-2021 for Vaccination site erythema, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Tingling on my right foot), HYPOAESTHESIA (Numbness on my right foot) and DERMATITIS ACNEIFORM (the injection site has a little pimple) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.
Near narcoleptic sleep events, twice. Just fall asleep despite being well rested and sleep for 4-5 extra hpurs. This includes sleeping through alarms and recieving phone calls.
I started getting joint pain in all of my joints. It got progressively worse. In May, I got into my doctor and also I had a lot of fatigue. My hips and my hands is where it's the worse but includes elbows, shoulders and sometimes the knees.  June 12 - Rheumatoid specialist - put me on a prednisone taper to see if my symptoms would be resolved - 2 weeks. I responded to that.  Currently, I take Motrin as needed for pain but it doesn't help that much.
6 inch patch of rash over the top of my left shoulder and down across the armpit with itching; 6 inch patch of rash over the top of my left shoulder and down across the armpit; body aches; flash headache; injection site swelled up and got very hot; injection site swelled up; a band of red 2 inches below the injection site; Redness; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE SWELLING (injection site swelled up) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included WELLNESS FORMULA for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced ERYTHEMA (Redness) and TENDERNESS (tenderness). On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE SWELLING (injection site swelled up) and VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site). On 26-Feb-2021, the patient experienced HEADACHE (flash headache). On 27-Feb-2021, the patient experienced MYALGIA (body aches). On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit). On 21-Feb-2021, VACCINATION SITE WARMTH (injection site swelled up and got very hot) and VACCINATION SITE SWELLING (injection site swelled up) had resolved. At the time of the report, ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching), VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site), HEADACHE (flash headache), MYALGIA (body aches) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Soreness; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-061058 (E2B Linked Report).; Sender's Comments:  MOD21-061058:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information on patient's medical history or concurrent conditions was provided. On 28-APR-2015, the patient was vaccinated with an expired dose of (Merck) VARIVAX lot # J003703, expiration date 27-MAR-2015 (dose and route of administration were not reported). No information on patient's concomitant medication was provided. No adverse events were reported. Additional information has been requested.
about 4-5 minutes after vaccine was administered Patient felt dizzy, both arms turned pink, face and lips turned pale,  Epinephrine 0.3 administered , O2 via nasal canula given 911 called and Patient transported to hospital for evaluation
pt had a h/a,chills,nausea feeling & weakness around 1445;by 1600 the h/a has resolved but other sx are still present;pt was recommended rest,fluids & APAP;
shingles; Initial information received on 12-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves a 94 years old male patient who developed shingles, while receiving vaccine INFLUENZA VACCINE.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious event "shingles" (herpes zoster) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (shingles).  At time of reporting, the outcome was Unknown for the event shingles.
Few hours after vaccination, flushing on right side of cheek noted by mother, was intermittent (came and went several times). Next day started with swelling of upper lip.
Spoke with patient 2/10/23 around 0800, patient relates no adverse reactions since time of administration.
pt recv vax 13SEP95 & 30JAN97 pt devel a mild case of chickenpox consist of 40 spots & a mild fever of about 101;It was reported that pt sibling contracted chickenpox on 12FEB97 (WAES #97021055);
64 Y female with history of HTN, obesity BMI>40yr, hypothyroidism, and psoriasis presenting with SOB and CP since 7/31 admitted for COVID PNA.  Patient Active Hospital Problem List:  #CORONAVIRUS COVID-19 PNEUMONIA  Pt was vaccinated w/ COVID Pfizer vaccine in Jan/Feb 2021. Became symptomatic on 7/31 and tested COVID + on 8/3. Has started to experience progressively worsening DOE with continuous dry cough. Desatted to 89% on RA in the ED on 8/10/21. S/p decadron 6 mg x1 in ED. Admitted for COVID PNA. She was started on supplemental O2, Remdesivir, and prednisone 6mg daily. She remained stable on 1-2L NC at rest. S/p a 5 day course of Remdesivir; however, she still required 1-2L NC at rest. She was discharged with home O2 and to complete a total 10 day course of prednisone 6mg with referral to the oxygen clinic. Pt discharged on 8/14/21.
At the second morning , after the first vaccione, I start feeling hoarseness in my voice. It?s been 2 month and my voice have not return to normal.
Vaccine given 2 days after its expiration date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 2 days after its expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 2 days after its expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 2 days after its expiration date) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were provided.
Immediately after the vaccine administration, patient complained of being lightheaded. About 30 seconds to 1 minute afterwards, patient had a syncope (fainting) episode while he was sitting on the chair. The episode lasted for about 10 to 20 seconds and patient regained consciousness. EMTs arrived and took vitals. Everything checked out to be normal. Patient was let go after a total of 30 minutes of observation. Patient stated this is not the first time this happened to him. A year ago, the same thing happen when he went for a blood draw. He also stated that he was a little nervous before the vaccine administration and that he is a little bit scared of needles.
Nausea, fever, controlled shaking, body aches -  24hrs nex day aches - 24hrs  Aleve and fluids
hurts all over; pain in arm of injection; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm of injection), ARTHRALGIA (joint pain) and PAIN (hurts all over) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (patient has lump and had breast cancer were noted.) and Lupus-like syndrome since an unknown date.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in arm of injection), ARTHRALGIA (joint pain) and PAIN (hurts all over). At the time of the report, VACCINATION SITE PAIN (pain in arm of injection), ARTHRALGIA (joint pain) and PAIN (hurts all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    This case was linked to MOD-2021-035881 (Patient Link).
16yoF patient came to our Moderna  Vax clinic on 4/23/21, inadvertently received COVID-19 vaccine Moderna lot 007C21A ext 10/12/21. FDA  for moderna is for age over 18. Patient was notified on the incident. Our  physician was notified and consulted for feedback. Patient reported no side effects after 1st dose. Clinic leadership immediately convened meetings for process improvement with on-going audit to prevent future incident. The case was discussed with physician and another physician over her vaccination. Their recommendation was to offer Pfizer vaccine. Legal guardian consented to 2nd dose Pfizer, lot EW0167, which was given on 5/25/21. Patient reported no side effect after the dose.
The morning after the second injection, Woke up nauseated, some vomiting, intermittent chills, no fever.  All symptoms were gone within 6 hours.  Within a few weeks (timeline not exact) a lump was noticed under the left armpit, which remains
Got the shot Thursday night, felt great Thursday, felt great Friday, was so excited about not having a reaction. Sunday, didn't wake up until 2:30 in the afternoon, and the following days I was clearly back into my previous long term Epstein Barr virus, and chronic fatigue symptoms. I have two doctors. The doctor told me that the vaccine triggered the Epstein Barr virus. Prescribed an anti-inflammatory. The forward doctor said a lot of her patients have experienced symptoms returning and other symptoms of previous conditions and said that for most of them it lasts for 2-3 months, and they're headed to feeling better again (told me this over the phone). No tests or labs. I think I spoke with the Forward doctor first, and when I wasn't feeling better after 3 months, saw the other doctor. January 27th this year my symptoms were gone. Unwilling to get a booster because of this. I was unable to function and take care of daily activities.
The patient came in for second dose of the Pfizer vaccine for kids age(5-11) vaccine was given and after administering the vaccine only did the pharmacist realize that the 1st dose was given a week earlier.
arm hurts like crazy; This case was reported by a consumer and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd December 2019, the patient received the 2nd dose of Shingrix. In December 2019, less than a week after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient reported that the arm hurts like crazy.
Fever during night, followed by pain in left arm, armpit, and down left side, then rash from torso up to breasts and neck
after receiving 2nd dose of covid vaccine, pt was told to sit for 15 min. once patient got up he felt dizzy and fell. Ambulance came and provided first aid. Then patient left with caregiver . He will go to a hospital.
Back pain; swelling; pinched nerve; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the parent received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Unknown.     No Medical History information was reported.    On an unknown date, the parent received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment drugs were not reported concomitant drugs were not reported   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Followup received on 13-06-2021 is non significant; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: EL3247), in left arm, on 15Feb2021 as dose 2, single (Lot number: EN5318), in left arm, on 02Oct2021 as dose 3 (booster), single (Lot number: FE3592), in left arm and on 06May2022 as dose 4 (booster), single (Lot number: FK9895) at the age of 69 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: DICLOFENAC SODIUM; ATORVASTATIN; VITAMIN D 3. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication: Covid-19 treatment.
I had a breakthrough case of COVID 19. Very mild cold symptoms, no fever,  Symptoms and positive test began April 20. 2022. Took Paxlovid for 5 days.  Symptoms over and negative test by April 27. Note:  I had one more vaccination March 21, 2021 and a booster 09/25/21 and a second Booster 04/12/22.  All Pfizer. The breakthrough case of COVID followed all of these vaccinations.
Elbows locked and painfully to use.  Knees locked and painful to use.  Patient needed a cane for 3 days in order to walk.  Neck locked in place and painfully to move
had shoulder pain/it hurt up to his toe or finger, the big one, and starts from his elbow; pain went down a little bit because it hurt up to his toe or finger, the big one, and starts from his elbow; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), in May2021 as dose 1, single (Batch/Lot number: unknown) at the age of 69 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "had shoulder pain/it hurt up to his toe or finger, the big one, and starts from his elbow"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "pain went down a little bit because it hurt up to his toe or finger, the big one, and starts from his elbow". The events "had shoulder pain/it hurt up to his toe or finger, the big one, and starts from his elbow" and "pain went down a little bit because it hurt up to his toe or finger, the big one, and starts from his elbow" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, pain in extremity; patient was given unspecified treatment. Additional information: It was reported that the patient had shoulder pain on May2021 and still has it, the pain was not big but he has it day and night. It was also reported that on an unspecified date in 2021 patient's pain went down a little bit because it hurt up to his toe or finger, the big one, and starts from his elbow. Patient was given unspecified treatment for the events reported.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
very red; very swelled, raised area; itchy; painful; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 63-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 26Aug2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for pneumonia. The patient's relevant medical history was not reported. Concomitant medication(s) included: POTASSIUM CHLORIDE. The following information was reported: ERYTHEMA (non-serious), outcome "not recovered", described as "very red"; SWELLING (non-serious), outcome "not recovered", described as "very swelled, raised area"; PRURITUS (non-serious), outcome "not recovered", described as "itchy"; PAIN (non-serious), outcome "not recovered", described as "painful". Therapeutic measures were not taken as a result of erythema, swelling, pruritus, pain. Additional information: It has been getting progressively worst.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
I started feeling achy and cold all over and then got a fever (so far, high of 101.5). This just happened today so I don't know how quickly it will dissipate. PLEASE NOTE: I did not go to the doctor about this yet, but the form made me fill in some action taken to move forward and submit it.
NO additional AE; adverse event of expired VAQTA, with an expiration date of 6/4/2021, which was inadvertently administered on 6/7/2021; This spontaneous report was received from a medical assistant, referring to a patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.  On 07-JUN-2021, the patient was inadvertently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) 0.5 ml injection (route of administration and anatomical location were not reported; lot number T008698 has been verified to be a valid lot number, expiration date 04-JUN-2021) for prophylaxis. The hepatitis a vaccine, inactivated (VAQTA) did not undergone any temperature excursion. No additional adverse effect was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T008698; expirationdate: 04-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
I went to the clinic for my third dose of Covid. Waited my 30 minutes and I went to stand up and I couldn't because I was dizzy. They moved me to another room and I waited an hour. After that hour I felt better and went home. During the day I felt bad, I had a headache, bone pain, and I had a fever. As the days go by I feel better.
Soreness at injection site that suddenly appeared and felt like the recovery period after each dose. Appeared/disappeared several times but with decreasing frequency over time. Radiating nerve pain from infection site down arm into hand. Off and on, sometimes starting with injection site soreness plus appearing other times as well. Both symptoms still occurring.
4 year old recieved 4 immunizations.  While ina a waiting area of the hopsital developed rapid onset of hives/rash requiring urgent visit to the emergency room. Given epinephrine, & benedryl 25mg with relief of symptoms.  No respiratory distress noted during this episode. Patient discharged from the ER with parent.
Patient in office for 2nd dose of COVID vaccine. I administered vaccine as I reviewed information with patient from the forms and she states she had vaccine within the last 3 weeks so I administered the vaccine. Once I was entering vaccine information into her chart she had received vaccine on 2/8/22 so it was a 5 days early and this vaccine only has a 4 day grace period. Charge nurse and patient notified and patient instructed to reschedule for her 3rd dose in 3 weeks from today so that she is covered appropriately. Patient verbalized understanding.
After 2nd dose of moderna vaccine shot that I got on 02/30/2021, I developed a severe headache and tinntus that lasts until present.
15 hours after the vaccine I came down with fever, headache, chills,  and body aches